Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to August 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $5.3B |
| Sales growthchange from the year before | +7.2% |
| Gross marginshare of sales left after the direct cost of what it sells | 17.4% |
| Operating marginshare of sales left after running the business | 4.4% |
| Net marginshare of sales kept as profit | 2.8% |
| Free-cash-flow marginspare cash generated per $100 of sales | 2.0% |
| Return on invested capitalprofit made on each $100 put into the business | 12.4% |
| Return on equityprofit vs. shareholders' accounting value | 11.3% |
| Debt / equitydebt vs. shareholders' accounting value | 0.14 |
| Change in share countnegative = the company is buying back its shares | +0.1% |
2 insiders sold $2.3M on the open market.
| Bahrambeygui Sherry S.Director | SoldAug 3 | 3,499 shat $197.38 · $691K |
| Bahrambeygui Sherry S.Director | SoldJul 31 | 1,000 shat $194.46 · $194K |
| Bahrambeygui Sherry S.Director | SoldJul 29 | 1,000 shat $192.66 · $193K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy